The recent storm over possible dangerous
complications from popular arthritis pain medications, such as
Vioxx® and Celebrex®, may be opening the door wider for
increased used of orthotic intervention in knee osteoarthritis
(OA). This is good news not only for orthotic manufacturers,
suppliers, orthotists, and other health professionals; its also
good news for patients.